Medscape10 天
Mild Persistent Asthma and Inhaled Corticosteroids: Is Daily Therapy Really Necessary?
Although NIH guidelines recommend daily inhaled corticosteroids as the mainstay of treatment for mild persistent asthma, patient adherence is variable. In this double-blind trial, researchers ...
MedPage Today1 个月
Asthma Drug Did Not Reduce Symptom Duration in Mild to Moderate COVID
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of ...
pharmaphorum1 个月
AZ, Avillion's Airsupra aces asthma rescue therapy trial
BATURA enrolled patients with intermittent or mild persistent asthma ... was based on the MANDALA trial in patients with moderate to severe asthma and the DENALI study in mild to moderate asthma ...
Pharmabiz1 个月
AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild ...
The trial included patients with intermittent or mild persistent asthma, including those on short-acting beta2-agonist (SABA) alone, low-dose inhaled corticosteroid (ICS) maintenance therapy, or ...
Medpage Today on MSN1 个月
Asthma Drug Did Not Reduce Symptom Duration in Mild to Moderate COVID
Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of symptoms, ...